Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
Rybak JM, Marx K, Martin CA. Rybak JM, et al. Pharmacotherapy. 2014 Nov;34(11):1198-208. doi: 10.1002/phar.1491. Epub 2014 Sep 30. Pharmacotherapy. 2014. PMID: 25266820 Review.
New milestones achieved in fluoroquinolone safety.
Tillotson GS, Rybak J. Tillotson GS, et al. Among authors: rybak j. Pharmacotherapy. 2001 Mar;21(3):358-60. doi: 10.1592/phco.21.3.358.34205. Pharmacotherapy. 2001. PMID: 11253861 Review. No abstract available.
Current and prospective treatments for multidrug-resistant gram-positive infections.
Rybak JM, Barber KE, Rybak MJ. Rybak JM, et al. Among authors: rybak mj. Expert Opin Pharmacother. 2013 Oct;14(14):1919-32. doi: 10.1517/14656566.2013.820276. Epub 2013 Jul 22. Expert Opin Pharmacother. 2013. PMID: 23876168 Review.
Tedizolid Phosphate: a Next-Generation Oxazolidinone.
Rybak JM, Roberts K. Rybak JM, et al. Infect Dis Ther. 2015 Feb 24;4(1):1-14. doi: 10.1007/s40121-015-0060-3. Online ahead of print. Infect Dis Ther. 2015. PMID: 25708156 Free PMC article.
The β-Lactams Strike Back: Ceftazidime-Avibactam.
Zasowski EJ, Rybak JM, Rybak MJ. Zasowski EJ, et al. Among authors: rybak jm, rybak mj. Pharmacotherapy. 2015 Aug;35(8):755-70. doi: 10.1002/phar.1622. Pharmacotherapy. 2015. PMID: 26289307 Free PMC article. Review.
Pharmacokinetic and Pharmacodynamic Analyses of Ceftaroline in Adults with Cystic Fibrosis.
Autry EB, Rybak JM, Leung NR, Gardner BM, Burgess DR, Anstead MI, Kuhn RJ. Autry EB, et al. Among authors: rybak jm. Pharmacotherapy. 2016 Jan;36(1):13-8. doi: 10.1002/phar.1681. Epub 2016 Jan 9. Pharmacotherapy. 2016. PMID: 26748559 Clinical Trial.
Imipenem-Cilastatin-Relebactam: A Novel β-Lactam-β-Lactamase Inhibitor Combination for the Treatment of Multidrug-Resistant Gram-Negative Infections.
Smith JR, Rybak JM, Claeys KC. Smith JR, et al. Among authors: rybak jm. Pharmacotherapy. 2020 Apr;40(4):343-356. doi: 10.1002/phar.2378. Epub 2020 Mar 9. Pharmacotherapy. 2020. PMID: 32060929
Utilizing Monte Carlo Simulations to Optimize Institutional Empiric Antipseudomonal Therapy.
Tennant SJ, Burgess DR, Rybak JM, Martin CA, Burgess DS. Tennant SJ, et al. Among authors: rybak jm. Antibiotics (Basel). 2015 Dec 11;4(4):643-52. doi: 10.3390/antibiotics4040643. Antibiotics (Basel). 2015. PMID: 27025644 Free PMC article.
Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections.
Brade KD, Rybak JM, Rybak MJ. Brade KD, et al. Among authors: rybak jm. Infect Dis Ther. 2016 Mar;5(1):1-15. doi: 10.1007/s40121-016-0103-4. Epub 2016 Feb 1. Infect Dis Ther. 2016. PMID: 26831328 Free PMC article. Review.
18 results
Jump to page
Feedback